HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia-Lymphoma. 2018

Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

Human T-cell leukemia virus type 1 (HTLV-1), the first reported human oncogenic retrovirus, is the etiologic agent of highly aggressive, currently incurable diseases such as adult T-cell leukemia-lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 proteins, including Tax and HBZ, have been shown to have critical roles in HTLV-1 pathogenicity, yet the underlying mechanisms of HTLV-1-driven leukemogenesis are unclear. The frequent disruption of genetic and epigenetic gene regulation in various types of malignancy, including ATL, is evident. In this review, we illustrate a focused range of topics about the establishment of HTLV-1 memory: (1) genetic lesion in the Tax interactome pathway, (2) gene regulatory loop/switch, (3) disordered chromatin regulation, (4) epigenetic lock by the modulation of epigenetic factors, (5) the loss of gene fine-tuner microRNA, and (6) the alteration of chromatin regulation by HTLV-1 integration. We discuss the persistent influence of Tax-dependent epigenetic changes even after the disappearance of HTLV-1 gene expression due to the viral escape from the immune system, which is a remaining challenge in HTLV-1 research. The summarized evidence and conceptualized description may provide a better understanding of HTLV-1-mediated cellular transformation and the potential therapeutic strategies to combat HTLV-1-associated diseases.

UI MeSH Term Description Entries

Related Publications

Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
October 2007, Current hematologic malignancy reports,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
December 2003, Reviews in clinical and experimental hematology,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
January 2011, Advances in cancer research,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
January 1998, Hematology (Amsterdam, Netherlands),
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
December 2000, La Revue de medecine interne,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
October 2023, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
June 2019, Blood,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
May 2023, Blood,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
January 2016, The Pan African medical journal,
Makoto Yamagishi, and Dai Fujikawa, and Toshiki Watanabe, and Kaoru Uchimaru
January 2007, Frontiers in bioscience : a journal and virtual library,
Copied contents to your clipboard!